Lyrica (pregabalin) is not an SSRI. It belongs to a completely different drug class called anticonvulsants and works through an entirely separate mechanism in the brain. Its FDA prescribing label states explicitly that pregabalin is inactive at serotonin receptors and does not inhibit serotonin reuptake, which is the defining action of every SSRI.
The confusion likely comes from the fact that Lyrica and SSRIs are sometimes prescribed for overlapping conditions, particularly anxiety. But these two medications work in fundamentally different ways.
How Lyrica Actually Works
Lyrica binds to a specific part of voltage-gated calcium channels in the nervous system, known as the alpha-2-delta subunit. By attaching there, it reduces the amount of calcium that flows into nerve cells, which in turn dials down the release of several chemical messengers involved in pain signaling and nerve excitability. These include glutamate (a stimulating neurotransmitter), noradrenaline, and substance P (a pain-related compound).
The net effect is a calming of overactive nerve circuits. This is why Lyrica helps with nerve pain, seizures, and anxiety: all three involve excessive neural signaling, and Lyrica dampens that activity at the source. Interestingly, pregabalin was originally designed to mimic GABA, a calming brain chemical, but research showed it doesn’t actually affect GABA receptors at all. Its benefits come entirely from that calcium channel mechanism.
How SSRIs Work Differently
SSRIs, or selective serotonin reuptake inhibitors, target a single neurotransmitter system: serotonin. Normally, after serotonin is released between nerve cells, it gets reabsorbed (reuptaken) by the sending cell. SSRIs block that reabsorption, leaving more serotonin available in the gap between cells. Over weeks, this shifts brain chemistry in ways that reduce depression and anxiety symptoms.
Lyrica has no effect on this process. It doesn’t increase serotonin levels, block serotonin reuptake, or interact with serotonin receptors in any meaningful way. It also doesn’t affect dopamine reuptake. The two drugs operate on completely separate pathways in the nervous system, which is actually why they can sometimes be prescribed together.
Why the Two Get Compared
Lyrica and SSRIs overlap in one key area: generalized anxiety disorder (GAD). SSRIs are typically considered a first-line treatment for GAD in the United States, while Lyrica has been recommended as a potential first-line option by the World Federation of Societies of Biological Psychiatry, particularly for patients whose anxiety includes significant physical symptoms or sleep disruption.
When researchers pooled data from randomized controlled trials for GAD, pregabalin showed a mean effect size of 0.50, compared to 0.36 for SSRIs and 0.42 for SNRIs (a related antidepressant class). These numbers suggest pregabalin performs at least comparably to SSRIs for anxiety, though head-to-head comparisons are limited. For patients who don’t respond well to an SSRI or SNRI alone, adding pregabalin has been shown to be more effective than continuing the antidepressant by itself.
That said, Lyrica is not approved for depression, while SSRIs are. If your primary concern is depression rather than anxiety or pain, Lyrica would not be a substitute.
Different Side Effect Profiles
Because Lyrica and SSRIs act on different systems, their side effects look quite different. Lyrica commonly causes dizziness, drowsiness, dry mouth, blurred vision, weight gain, and swelling in the hands or feet. SSRIs are more associated with nausea, sexual dysfunction, insomnia or excessive sleepiness, and emotional blunting.
One important distinction: Lyrica is a Schedule V controlled substance in the United States, meaning it carries some risk of misuse. The DEA placed it in this category because clinical trials found an unusually high percentage of patients experienced euphoric effects, particularly at higher doses. Those effects tend to be short-lived and don’t typically persist with continued use, but they’re enough to warrant caution. SSRIs carry no abuse potential and are not scheduled.
Taking Lyrica and an SSRI Together
Because these medications work through independent pathways, they are sometimes prescribed together, particularly when someone has both anxiety and nerve pain, or when one medication alone isn’t providing enough relief. However, the combination does carry some interaction risks worth knowing about.
SSRIs can occasionally lower blood sodium levels, and combining them with anticonvulsants like pregabalin may increase that risk. Symptoms of low sodium include nausea, headache, confusion, muscle weakness, and difficulty concentrating. Both drugs can also cause drowsiness and dizziness on their own, and those effects tend to add up when taken together. If you’re on both, pay attention to how alert you feel before driving or doing anything that requires sharp reflexes.
What Lyrica Is Approved to Treat
Lyrica’s FDA-approved uses reflect its role as a nerve-calming medication rather than an antidepressant. It is approved for nerve pain caused by diabetes (diabetic neuropathy), nerve pain following shingles (postherpetic neuralgia), fibromyalgia, nerve pain from spinal cord injury, and as an add-on treatment for partial-onset seizures in adults. In Europe, it also carries an approval for generalized anxiety disorder, though that indication has not been granted in the U.S.
If you’ve been prescribed Lyrica and are wondering whether it covers the same ground as an SSRI, the short answer is that it may help with anxiety but won’t address depression the way an SSRI would. The two medications serve different primary purposes and are not interchangeable.